Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ratner

Showing results (11-20 of 4,048) with videos related to

Pageof 405
Sort By:
Nature Biotechnology|December 10, 2014
Celgene wagers on Sutro's cell-free platform to ramp up ADCsMark Ratner
Nature Biotechnology|June 10, 2016
Gilead bets big on Nimbus' fatty liver disease drugMark Ratner
Annals of Internal Medicine|December 1, 1986
Delta hepatitis outbreak in a group of patients with leukemiaL Ratner
Nature Biotechnology|March 30, 1999
Cancer pathways' target not validated by clinical resultsM Ratner
Analytical Biochemistry|December 1, 1983
A radiochemical assay for argininosuccinate synthetase with [U-14C]aspartateS Ratner
Nature Biotechnology|April 10, 2010
Roche plans for more convenient-to-use Herceptin and RituxanMark Ratner
Nature Biotechnology|July 10, 2008
Dyax backs albuminMark Ratner
Bulletin of the New York Academy of Medicine|March 25, 2009
The Evolution of Our Present Knowledge of HypersensitivenessB Ratner
Nature Biotechnology|September 9, 2016
Strata rolls out drug-matching service, offers free tumor profilingMark Ratner
Nature Biotechnology|May 10, 2017
Genomics pioneer gets its first drugMark Ratner
Pageof 405

Showing results (11-20 of 4,048) with videos related to

Sort By:
Pageof 405
Nature Biotechnology|December 10, 2014
Celgene wagers on Sutro's cell-free platform to ramp up ADCsMark Ratner
Nature Biotechnology|June 10, 2016
Gilead bets big on Nimbus' fatty liver disease drugMark Ratner
Annals of Internal Medicine|December 1, 1986
Delta hepatitis outbreak in a group of patients with leukemiaL Ratner
Nature Biotechnology|March 30, 1999
Cancer pathways' target not validated by clinical resultsM Ratner
Analytical Biochemistry|December 1, 1983
A radiochemical assay for argininosuccinate synthetase with [U-14C]aspartateS Ratner
Nature Biotechnology|April 10, 2010
Roche plans for more convenient-to-use Herceptin and RituxanMark Ratner
Nature Biotechnology|July 10, 2008
Dyax backs albuminMark Ratner
Bulletin of the New York Academy of Medicine|March 25, 2009
The Evolution of Our Present Knowledge of HypersensitivenessB Ratner
Nature Biotechnology|September 9, 2016
Strata rolls out drug-matching service, offers free tumor profilingMark Ratner
Nature Biotechnology|May 10, 2017
Genomics pioneer gets its first drugMark Ratner
Pageof 405